Matches in Nanopublications for { ?s ?p "[Subgroup analyses showed that lower expression of miR-375 was significantly related with poor OS in patients with esophageal carcinoma (HR = 2.24, 95% CI 1.69-2.96, P < 0.001) and non-small-cell lung cancer (NSCLC) (HR = 1.71, 95% CI 1.31-2.24, P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1238143.RATYFz_lPYlkFiMEULdd2KcPkcbILG9UtHeREQf3tZQ0g130_assertion description "[Subgroup analyses showed that lower expression of miR-375 was significantly related with poor OS in patients with esophageal carcinoma (HR = 2.24, 95% CI 1.69-2.96, P < 0.001) and non-small-cell lung cancer (NSCLC) (HR = 1.71, 95% CI 1.31-2.24, P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238143.RATYFz_lPYlkFiMEULdd2KcPkcbILG9UtHeREQf3tZQ0g130_provenance.
- NP1238144.RAPiDnOUXu44jRLfctEEnQNsZt0Yq4B3lA0MNspBcPQGs130_assertion description "[Subgroup analyses showed that lower expression of miR-375 was significantly related with poor OS in patients with esophageal carcinoma (HR = 2.24, 95% CI 1.69-2.96, P < 0.001) and non-small-cell lung cancer (NSCLC) (HR = 1.71, 95% CI 1.31-2.24, P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238144.RAPiDnOUXu44jRLfctEEnQNsZt0Yq4B3lA0MNspBcPQGs130_provenance.